Omeros Corporation (OMER)
OMER trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$18.88
-3.82% on the day
Market cap
$1.4B
Small cap
Revenue
No annual revenue filed since the period ending 2020-12-31
Net income
No annual revenue filed since the period ending 2020-12-31
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | OMER on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2009 |
| SEC CIK | 0001285819 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | WA |
Financials
No annual revenue filed since the period ending 2020-12-31.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2025-11-14 |
| Latest annual report FORM 10-K | 10-K | 2026-03-31 |
| Latest quarterly / interim FORM 10-Q | 10-Q | 2026-08-12 |
| Latest current report | 8-K | 2026-08-13 |
| Latest proxy | DEF 14A | 2026-04-30 |
Source: SEC EDGAR submissions feed, 808 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -0.3% |
| 1 month | +8.9% |
| 3 months | +102.7% |
| Year to date | +8.8% |
| 1 year | +346.1% |
| From 52-week high | -11.2% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| ANAB | AnaptysBio Inc. | $45.59 | -0.98% | $1.3B |
| RAPP | Rapport Therapeutics Inc. | $28.99 | -3.85% | $1.4B |
| KLRA | Kailera Therapeutics Inc. | $10.77 | -4.94% | $1.4B |
| AAPG | Ascentage Pharma Group International American Depository Shares | $15.06 | -1.63% | $1.4B |
| KRSA | Korsana Biosciences Inc. | $31.66 | -6.99% | $1.4B |
| NKTR | Nektar Therapeutics | $37.92 | -4.82% | $1.3B |
| GHRS | GH Research PLC | $18.85 | -5.84% | $1.3B |
| PCRX | Pacira BioSciences Inc. | $36.31 | -0.11% | $1.4B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier